Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases
Eline Geervliet, Ruchi Bansal
Cells (2020) Vol. 9, Iss. 5, pp. 1212-1212
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Hepatic fibrosis 2022: Unmet needs and a blueprint for the future
Scott L. Friedman, Massimo Pinzani
Hepatology (2021) Vol. 75, Iss. 2, pp. 473-488
Open Access | Times Cited: 284
Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies
Karen E. Martin, Andrés J. Garcı́a
Acta Biomaterialia (2021) Vol. 133, pp. 4-16
Open Access | Times Cited: 242
Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis
Liang Shan, Fengling Wang, Dandan Zhai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114472-114472
Open Access | Times Cited: 42
The Role of the Gut Microbiome in Liver Cirrhosis Treatment
Na Young Lee, Ki Tae Suk
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 199-199
Open Access | Times Cited: 86
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam, Paul Saleeb, Shyam Kottilil
Cells (2021) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 81
Chemopreventive effects of hesperidin against paclitaxel-induced hepatotoxicity and nephrotoxicity via amendment of Nrf2/HO-1 and caspase-3/Bax/Bcl-2 signaling pathways
Cihan Gür, Fatih Mehmet Kandemir, Cüneyt Çağlayan, et al.
Chemico-Biological Interactions (2022) Vol. 365, pp. 110073-110073
Closed Access | Times Cited: 56
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
Eleonora Binatti, Alessio Gerussi, Donatella Barisani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6649-6649
Open Access | Times Cited: 39
Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
Mona A. Omar, Mohamed M. Omran, Khaled Farid, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1852-1852
Open Access | Times Cited: 27
Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
Yuanquan Zhao, Xiwen Deng, Guo-Qi Xu, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 23
Quantification of Serum Matrix Metallopeptide 7 Levels May Assist in the Diagnosis and Predict the Outcome for Patients with Biliary Atresia
Jia‐Feng Wu, Yung–Ming Jeng, Huey‐Ling Chen, et al.
The Journal of Pediatrics (2019) Vol. 208, pp. 30-37.e1
Closed Access | Times Cited: 72
Key Players of Hepatic Fibrosis
Reham M. Dawood, Mai Abd El-Meguid, Ghada M. Salum, et al.
Journal of Interferon & Cytokine Research (2020) Vol. 40, Iss. 10, pp. 472-489
Closed Access | Times Cited: 50
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting
Nabil Mohie Abdel‐Hamid, Shimaa A. Abass
Molecular Biology Reports (2021) Vol. 48, Iss. 9, pp. 6525-6538
Closed Access | Times Cited: 48
Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis
Eline Geervliet, Sílvia Moreno, Luca Baiamonte, et al.
Journal of Controlled Release (2021) Vol. 332, pp. 594-607
Open Access | Times Cited: 44
Chrysin mitigates diclofenac-induced hepatotoxicity by modulating oxidative stress, apoptosis, autophagy and endoplasmic reticulum stress in rats
Behçet Varışlı, Cüneyt Çağlayan, Fatih Mehmet Kandemir, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 1, pp. 433-442
Closed Access | Times Cited: 33
Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis
Yumei Hao, Kaichao Song, Xiaochuan Tan, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 20739-20757
Closed Access | Times Cited: 33
Green Synthesis of Silymarin–Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis
Abdullah Saad Abdullah, Ibrahim El Tantawy El Sayed, Abdel Moneim El‐Torgoman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5420-5420
Open Access | Times Cited: 32
The Space of Disse: The Liver Hub in Health and Disease
Carlos Sanz‐García, Anabel Fernández‐Iglesias, Jordi Gracia‐Sancho, et al.
Livers (2021) Vol. 1, Iss. 1, pp. 3-26
Open Access | Times Cited: 36
A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases
Aliah R. Alshanwani, Hanan Hagar, Sameerah Shaheen, et al.
European Journal of Pharmacology (2022) Vol. 923, pp. 174910-174910
Closed Access | Times Cited: 25
The protective effects of sesamol and/or the probiotic, Lactobacillus rhamnosus, against aluminum chloride-induced neurotoxicity and hepatotoxicity in rats: Modulation of Wnt/β-catenin/GSK-3β, JAK-2/STAT-3, PPAR-γ, inflammatory, and apoptotic pathways
Karema Abu‐Elfotuh, Heba Mohammed Refat M. Selim, Omnia Karem M. Riad, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes account for organ injury, regeneration or atrophy
Hao Long, Julia Lichtnekert, Joachim Andrassy, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Communication between nonalcoholic fatty liver disease and atherosclerosis: Focusing on exosomes
Xiaona Zhao, Xinxin Kong, Zhoujun Cui, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 193, pp. 106690-106690
Open Access | Times Cited: 5
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis
Yongtao Wang, Ben D. Leaker, Guoliang Qiao, et al.
Hepatology Communications (2024) Vol. 8, Iss. 11
Open Access | Times Cited: 5
A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis
Charlotte Burelle, Valentin Clapatiuc, Sonia Deschênes, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis
Tzu-Yu Pu, Kai-Cheng Chuang, Min‐Che Tung, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116490-116490
Open Access | Times Cited: 4
Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression
Anindita Banerjee, Patrizia Farci
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8641-8641
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top